{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:05:31Z","timestamp":1788584731739,"version":"build-2803163510"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100001844","name":"Scleroderma Foundation","doi-asserted-by":"publisher","award":["New Investigator Grant"],"award-info":[{"award-number":["New Investigator Grant"]}],"id":[{"id":"10.13039\/100001844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis Care &amp; Research"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Despite efforts at early detection, patients with systemic sclerosis (SSc) pulmonary hypertension (PH) present with advanced disease. We sought to determine whether endothelial biomarkers (asymmetric dimethylarginine [ADMA], soluble endoglin [sEng], and pentraxin\u20103 [PTX\u20103]) can determine SSc\u2010PH risk or differentiate between SSc\u2010PH subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      ADMA, sEng, and PTX\u20103 were measured by enzyme\u2010linked immunosorbent assay in four groups: 1) 18 healthy controls, 2) 74 patients with SSc\u2010PH, 3) 44 patients at high risk for PH features, and 4) 10 patients with low risk for PH features. High\u2010risk features included a diffusion capacity (DL\n                      <jats:sc>co<\/jats:sc>\n                      ) less than 55% with a forced vital capacity (FVC) greater than 70%, an FVC\/DL\n                      <jats:sc>co<\/jats:sc>\n                      ratio of &gt;1.6, or a right ventricular systolic pressure on an echocardiogram greater than or equal to 40\u2009mm Hg. ADMA, sEng, and PTX\u20103 were compared between these four groups as well as stratified based on the three SSc\u2010PH clinical classification groups (pulmonary arterial hypertension [PAH], left\u2010heart disease, and interstitial lung disease [ILD]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PTX\u20103 was significantly lower in subjects with SSc at low risk for PH (median 27.0 pg\/ml [interquartile range (IQR) 19.0\u201347.3];\n                      <jats:italic>P<\/jats:italic>\n                      &lt;\u20090.003) than the other groups. The area under the receiver operating characteristic curve was 0.87 (95% confidence interval 0.76\u20130.98,\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.0002) to differentiate low risk from high risk for patients with PH. PTX\u20103 was significantly lower in SSc\u2010PH from disease of the left side of the heart (57.5 pg\/ml [IQR 39.8\u201379.0];\n                      <jats:italic>P<\/jats:italic>\n                      &lt;\u20090.01) compared to SSc\u2010PH from either PAH (85.5 pg\/ml [IQR 56.3\u2013104.5]) or ILD (90.3 pg\/ml [IQR 74.9\u2013111.0]). Neither ADMA nor sEng differed between the four groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PTX\u20103 is a promising biomarker of PH risk status in patients with SSc as well as a possible marker of precapillary PH, which should be validated in an external cohort.<\/jats:p>\n                    <jats:p>\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/acr25180-toc-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acr.25180","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:35:11Z","timestamp":1687826111000},"page":"266-272","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endothelial Biomarkers of Systemic\n                    <scp>Sclerosis\u2013Associated<\/scp>\n                    Pulmonary Hypertension"],"prefix":"10.1002","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5125-1801","authenticated-orcid":false,"given":"Matthew R.","family":"Lammi","sequence":"first","affiliation":[{"name":"Louisiana State University Health Sciences Center, University Medical Center\u2010New Orleans, and New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center  New Orleans Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen D.","family":"Kolstad","sequence":"additional","affiliation":[{"name":"University of California Los Angeles  Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[{"name":"University Medical Center\u2010New Orleans, New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, and Tulane University School of Medicine  New Orleans Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avani","family":"Khatri","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine  Palo Alto California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Utz","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine  Palo Alto California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Steen","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center  Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine and Palo Alto VA Health Care System  Palo Alto California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203301"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30541"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0517-5"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118851"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045834"},{"issue":"113","key":"e_1_2_7_7_1","first-page":"102","article-title":"Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function","volume":"36","author":"Kawashiri SY","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38953"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.110445"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken100"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000093846"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000168414.06853.f0"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken346"},{"issue":"100","key":"e_1_2_7_14_1","first-page":"129","article-title":"The role of asymmetric dimethylarginine alone and in combination with N\u2010terminal pro\u2010B\u2010type natriuretic peptide as a screening biomarker for systemic sclerosis\u2010related pulmonary arterial hypertension: a case control study","volume":"34","author":"Thakkar V","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101243"},{"key":"e_1_2_7_16_1","first-page":"A2909","article-title":"Detection score for pulmonary hypertension in systemic sclerosis patients: observations from the PHAROS registry [abstract]","volume":"201","author":"Kolstad KD","year":"2020","journal-title":"Am J Respir Critical Care Med"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"e_1_2_7_18_1","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy EC","year":"1988","journal-title":"J Rheumatol"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02734-9"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304554"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2007.03.002"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10747"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3482"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.310097"},{"issue":"71","key":"e_1_2_7_25_1","first-page":"S30","article-title":"Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis","volume":"30","author":"Hinchcliff M","year":"2012","journal-title":"Clin Exp Rheumatol"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.25180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.25180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.25180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:44:22Z","timestamp":1775864662000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.25180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1002\/acr.25180"],"URL":"https:\/\/doi.org\/10.1002\/acr.25180","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"2023-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}